CIK: 0001617201 · Show all filings
Period: Q1 2022 (← Previous) (Next →)
Filing Date: May 16, 2022
Total Value ($000): $154,864 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GLPG | GALAPAGOS NV | 374,000 | $23,195 | 15.0% | $58.55 | — | SPON ADR | 36315X101 |
| PRTA | PROTHENA CORP PLC | 566,538 | $20,718 | 13.4% | $26.31 | +37.0% | SHS | G72800108 |
| — | ALBIREO PHARMA INC | 480,000 | $14,318 | 9.2% | $30.59 | — | COM | 01345P106 |
| — | GALAPAGOS NV | 195,000 | $12,094 | 7.8% | — | — | Call | 36315X901 |
| CRL | CHARLES RIV LABS INTL INC | 31,500 | $8,945 | 5.8% | $347.75 | -11.3% | COM | 159864107 |
| KALV | KALVISTA PHARMACEUTICALS INC | 589,270 | $8,686 | 5.6% | $19.16 | -25.0% | COM | 483497103 |
| CUE | CUE BIOPHARMA INC | 1,510,282 | $7,370 | 4.8% | $11.54 | -38.7% | COM | 22978P106 |
| ALDX | ALDEYRA THERAPEUTICS INC | 1,400,239 | $6,224 | 4.0% | $7.18 | -44.5% | COM | 01438T106 |
| MGTX | MEIRAGTX HLDGS PLC | 380,700 | $5,273 | 3.4% | $15.40 | 0.0% | COM | G59665102 |
| — | KEZAR LIFE SCIENCES INC | 300,000 | $4,986 | 3.2% | $5.82 | — | COM | 49372L100 |
| — | CONVEY HEALTH SOLUTIONS HLDG | 748,134 | $4,893 | 3.2% | $9.97 | — | COM | 21258C108 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 22,704 | $3,707 | 2.4% | $185.86 | -18.0% | COM | 02043Q107 |
| AGL | AGILON HEALTH INC | 140,000 | $3,549 | 2.3% | $31.52 | -34.6% | COM | 00857U107 |
| STTK | SHATTUCK LABS INC | 798,718 | $3,403 | 2.2% | $9.93 | -42.9% | COM | 82024L103 |
| RCKT | ROCKET PHARMACEUTICALS INC | 203,268 | $3,224 | 2.1% | $23.61 | -26.8% | COM | 77313F106 |
| — | QUIDEL CORP | 25,675 | $2,887 | 1.9% | $112.44 | — | COM | 74838J101 |
| EHC | ENCOMPASS HEALTH CORP | 39,900 | $2,837 | 1.8% | $49.64 | +1.2% | COM | 29261A100 |
| OSCR | OSCAR HEALTH INC | 237,500 | $2,368 | 1.5% | $14.31 | -48.0% | CL A | 687793109 |
| — | ACCOLADE INC | 124,393 | $2,184 | 1.4% | $27.45 | — | COM | 00437E102 |
| SEM | SELECT MED HLDGS CORP | 90,788 | $2,178 | 1.4% | $12.31 | 0.0% | COM | 81619Q105 |
| CRSP | CRISPR THERAPEUTICS AG | 34,000 | $2,134 | 1.4% | $75.34 | -16.7% | NAMEN AKT | H17182108 |
| INMD | INMODE LTD | 50,000 | $1,846 | 1.2% | $44.79 | 0.0% | SHS | M5425M103 |
| MIRM | MIRUM PHARMACEUTICALS INC | 73,930 | $1,628 | 1.1% | $20.40 | 0.0% | COM | 604749101 |
| GMED | GLOBUS MED INC | 18,000 | $1,328 | 0.9% | $72.59 | -4.2% | CL A | 379577208 |
| SPRY | SILVERBACK THERAPEUTICS INC | 325,365 | $1,142 | 0.7% | $4.98 | -12.5% | COM | 82835W108 |
| NEO | NEOGENOMICS INC | 63,524 | $772 | 0.5% | $21.04 | 0.0% | COM NEW | 64049M209 |
| — | ORGANON & CO | 20,000 | $699 | 0.5% | — | — | Put | 68622V956 |
| CGTX | COGNITION THERAPEUTICS INC | 240,080 | $660 | 0.4% | $9.75 | -60.5% | COM | 19243B102 |
| PRQR | PROQR THRAPEUTICS N V | 599,288 | $542 | 0.3% | $4.47 | -25.1% | SHS EURO | N71542109 |
| — | SIO GENE THERAPIES INC | 670,300 | $449 | 0.3% | $1.98 | — | COMMON | 829399104 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 20,000 | $333 | 0.2% | $24.79 | -37.6% | COM | 462260100 |
| — | CYMABAY THERAPEUTICS INC | 93,923 | $292 | 0.2% | $3.38 | — | COM | 23257D103 |